With the investment, the company plans to take the next steps toward becoming a leading supplier in the multi-billion-dollar market for bone surgery devices, it states.

The company will expand its operations in the EU and the United States, it states.

“ZEISS brings unparalleled experience in surgical technology and a global network, while the EIC’s continued support and earlier grant financing underscore the European innovation ecosystem’s confidence in our solution,” says Visa Sippola, Co-founder and CEO of Surgify Medical. “With this funding and regulatory approvals in both the EU and the U.S., we are well-positioned to bring our unique technology to more surgeons and patients internationally.”